Viridian Therapeutics, Inc.

VRDN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001590750

SEC filings (opens in a new tab)

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Viridian Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of VRDN: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	122	135	+13
Shares	41.2M	43.1M	+1.83M (+4.4%)
Value	$1.21B	$1.10B	−$110.3M (−9.1%)

New holders (28)

Institutions that held Viridian Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to VRDN in Q1 2023
Institution	Shares	Value	% of portfolio
Pictet Asset Management SA	1,042,965	$26.5M	0.03%
Hood River Capital Management LLC	566,498	$14.4M	0.47%
Polar Capital Holdings Plc	550,000	$14.0M	0.10%
Artal Group S.A.	504,978	$12.8M	0.76%
Eagle Asset Management Inc	461,665	$11.7M	0.07%
Twinbeech Capital LP	66,612	$1.69M	0.03%
UBS Oconnor LLC	63,543	$1.62M	0.04%
Wells Fargo & Company	45,958	$1.17M	0.00%
Jane Street Group, LLC	43,045	$1.10M	0.00%
Renaissance Technologies LLC	35,800	$911.0K	0.00%
Profund Advisors LLC	32,900	$837.0K	0.05%
Tudor Investment Corp Et Al	24,110	$613.0K	0.01%
Cetera Advisors LLC	19,945	$507.4K	0.01%
Caption Management, LLC	15,000	$381.6K	0.08%
Janus Henderson Group PLC	13,414	$341.1K	0.00%
Verition Fund Management LLC	13,000	$330.7K	0.01%
LPL Financial LLC	10,080	$256.4K	0.00%
E Fund Management Co., Ltd.	10,044	$256.0K	0.02%
Raymond James & Associates	9,139	$232.5K	0.00%
Envestnet Asset Management Inc	8,414	$214.1K	0.00%
Voloridge Investment Management, LLC	8,119	$206.5K	0.00%
STRS Ohio	800	$20.0K	0.00%
Quantbot Technologies LP	700	$17.8K	0.00%
Lindbrook Capital, LLC	156	$3.97K	0.00%
TCI Wealth Advisors, Inc.	132	$3.36K	0.00%
Institutional & Family Asset Management, LLC	10	$254	0.00%
Ellevest, Inc.	9	$229	0.00%
Covestor Ltd	3	$0	0.00%

Sold out (15)

Institutions that held Viridian Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of VRDN in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
D. E. Shaw & Co., Inc.	338,167	$9.88M
Braidwell LP	313,403	$9.15M
Balyasny Asset Management LLC	304,552	$8.90M
Ameriprise Financial Inc	267,765	$7.82M
Polar Asset Management Partners Inc.	204,600	$5.98M
Moore Capital Management, LP	140,000	$4.09M
Trexquant Investment LP	35,887	$1.05M
Pura Vida Investments, LLC	35,003	$1.02M
Schonfeld Strategic Advisors LLC	31,400	$917.2K
Brookfield Asset Management Inc.	27,915	$815.4K
Mirabella Financial Services LLP	25,769	$752.7K
Caxton Associates LP	17,974	$525.0K
Squarepoint Ops LLC	17,207	$502.6K
Kula Investments, LLC	10,580	$309.0K
Gyon Technologies Capital Management, LP	8,086	$236.2K